MetLife Investment Management’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Hold |
27,540
| – | – | ﹤0.01% | 2294 |
|
|
2025
Q1 | $231K | Sell |
27,540
-506
| -2% | -$4.25K | ﹤0.01% | 2122 |
|
|
2024
Q4 | $209K | Hold |
28,046
| – | – | ﹤0.01% | 2287 |
|
|
2024
Q3 | $163K | Hold |
28,046
| – | – | ﹤0.01% | 2391 |
|
|
2024
Q2 | $187K | Buy |
28,046
+3,978
| +17% | +$26.5K | ﹤0.01% | 2295 |
|
|
2024
Q1 | $314K | Hold |
24,068
| – | – | ﹤0.01% | 1934 |
|
|
2023
Q4 | $307K | Hold |
24,068
| – | – | ﹤0.01% | 1979 |
|
|
2023
Q3 | $316K | Hold |
24,068
| – | – | ﹤0.01% | 1910 |
|
|
2023
Q2 | $616K | Buy |
24,068
+5,031
| +26% | +$129K | ﹤0.01% | 1562 |
|
|
2023
Q1 | $480K | Hold |
19,037
| – | – | ﹤0.01% | 1676 |
|
|
2022
Q4 | $438K | Hold |
19,037
| – | – | ﹤0.01% | 1726 |
|
|
2022
Q3 | $420K | Hold |
19,037
| – | – | ﹤0.01% | 1757 |
|
|
2022
Q2 | $273K | Hold |
19,037
| – | – | ﹤0.01% | 2088 |
|
|
2022
Q1 | $360K | Buy |
19,037
+6,788
| +55% | +$128K | ﹤0.01% | 1984 |
|
|
2021
Q4 | $228K | Buy |
12,249
+7,004
| +134% | +$131K | ﹤0.01% | 1975 |
|
|
2021
Q3 | $141K | Hold |
5,245
| – | – | ﹤0.01% | 2281 |
|
|
2021
Q2 | $164K | Buy |
+5,245
| New | +$164K | ﹤0.01% | 2274 |
|